Showing results (21-30 of 98) with videos related to
Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|August 27, 2013
TGF-β: an emerging player in drug resistanceDiede Brunen, Stefan M Willems, Udo Kellner, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Strategies for Sustainable Cancer CareDavid J Kerr, Anant Jani, Sir Muir GrayCurrent Opinion in Oncology|May 18, 2011
The emergence of 'omics for the management of colorectal cancerRachel S Midgley, David Church, David J KerrNature Clinical Practice. Gastroenterology & Hepatology|January 21, 2009
Evolution of nonsurgical therapy for colorectal cancerRachel S Midgley, Yoko Yanagisawa, David J KerrCurrent Opinion in Molecular Therapeutics|November 19, 2002
Clinical experience with adenovirus in cancer therapyDaniel H Palmer, Vivien Mautner, David J KerrBritish Medical Bulletin|November 8, 2002
Gene therapy for colorectal cancerDaniel H Palmer, Ming-Jen Chen, David J KerrJournal of Biomedicine & Biotechnology|April 11, 2003
Taking Gene Therapy into the ClinicDaniel H. Palmer, Ming-Jen Chen, David J. KerrFuture Oncology (London, England)|October 14, 2011
Challenges of cancer control in developing countries: current status and future perspectiveVanita Sharma, Stewart H Kerr, Zsana Kawar, et al.Trends in Cancer|October 2, 2024
Accessing the vasculature in cancer: revising an old hallmarkAdrian L Harris, David J Kerr, Francesco Pezzella, et al.Current Pharmaceutical Design|October 8, 2003
CB 1954: from the Walker tumor to NQO2 and VDEPTRichard J Knox, Philip J Burke, Shiuan Chen, et al.Pageof 10